Add Company
Join Now

Gedea Biotech Revenue and Competitors

License our Company Data API

Lund,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gedea Biotech's estimated annual revenue is currently $2M per year.(i)
  • Gedea Biotech's estimated revenue per employee is $125,938

Employee Data

  • Gedea Biotech has 16 Employees.(i)
  • Gedea Biotech grew their employee count by 45% last year.

Gedea Biotech's People

NameTitleEmail/Phone
1
QA DirectorReveal Email/Phone
2
Marketing and Communication ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M15-32%N/AN/A
#10
$10.1M48-9%N/AN/A
Add Company

What Is Gedea Biotech?

Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge, in the absence of itching. Standard treatment consists of antimicrobials, but recurrence rate is15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation's top ten threats to global health in 2019 and research into novel non-antimicrobial based treatments is timely.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2M

Revenue (est)

45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M1614%N/A
#2
$3.1M176%N/A
#3
$1.2M1838%N/A
#4
$4.4M18-14%N/A
#5
$1.4M1820%N/A